{"ticker": {"uuid": "064612ef-ec89-469d-8e5b-b34c033cf092", "symbol": "PAHC", "name": "Phibro Animal Health Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Phibro Animal Health (PAHC) After Russell Index Removals And The Case For Undervaluation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-10T05:15:25+00:00", "published_display": "10 Jul 2026 05:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Leaves Russell Indexes, Is The Stock A Bargain?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOQ1RjUWphNFpicVRVUFZVdXV4YmtxaldtTkVYYW0zMm5wcTlENEJ5bU9vY1NnV0hTZW9TOWg1b0NDVFRsVU1rdWcyOURvN2dkQzRraWZiRFNJdmRTTHJIWGdIckpzSXVlZ19xV2lKR29XRmFnNXlSTnB0TjFpMURoVXY2Y0NZbm1CT1FlV0theE0xcVE0MW1LTmFSUko2Zw?oc=5", "source_name": "Market source", "published_at": "2026-07-09T15:10:11+00:00", "published_display": "09 Jul 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Stock Looks Reasonable On Value But Stretched After 138% Gain", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQcjlFUzl2WDlIRkdTZXZWTVZsMmM3ZU9EN1VrNUhRajNXU0h5NzZMWTFubVQyUWhBb1JkWlUxSE1sdFFyRnYtNllsYUhLaGt4MkFzWFRYalJZNkpZNzhyOGg2akh3X3pjOWY4T1lRVFExNThXcFdNd2lXbm1BaWY1anR3WTNHamV4bnF6RDlQTzJMY083cVltTDRRSzc?oc=5", "source_name": "Market source", "published_at": "2026-07-09T10:12:39+00:00", "published_display": "09 Jul 2026 10:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Stock Loses Russell Index Spots And Investor Visibility", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPUm5qOHAzdFVVTjZDLWE1cXJWb1c1NlJjMURGSXlQS2RpRUUwS0plZUVZTE9yZUdUZ2JiWHgteG9QbnhtaV83R19tZXhMYXlRNE9nb3N2SjNaZHhSeEw2LXZqU2pkY3l2RUFPOWlqVzhkMVMtdVFrM1ZIMkQyX0J6QUFFUndJRUt0SW53ZUVTNVZIV3lJUUhkSDlCM1c?oc=5", "source_name": "Market source", "published_at": "2026-07-09T06:14:00+00:00", "published_display": "09 Jul 2026 06:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Las ETF que invierten en acciones de Phibro Animal Health Corporation Class A", "summary": "This article lists various ETFs that invest in Phibro Animal Health Corporation Class A stock, primarily focusing on small-cap and healthcare-related funds. It provides detailed financial data for each ETF, including market value, weight, issuer, management style, expense ratio, ", "url": "https://es.tradingview.com/symbols/FWB-PB8/etfs/", "source_name": "TradingView", "published_at": "2026-07-09T06:41:17", "published_display": "09 Jul 2026 06:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Stock Still Looks Below Fair Value Despite A 143% Return", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T22:53:07+00:00", "published_display": "08 Jul 2026 22:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chewy's Market Share Gains Are Driven by Health and Customer Loyalty", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQZEg0YW1rbEZTdkdhUDV4alFFRjBBQXZSVi00Z1RaY0FHa0xUTEtjY0ZKM01sak94dncyd2lTMmxHRjJfbXVLUEQzTE90bGVwZHcydkxZM3NjeGY0UUpnbnRmSlRscDRPT0pWbjFfX0QxbFJVZWxQZjF3by1BSDdzTWx2ZVRjc0FoZG1uSktBU3U4Z2dRVXY3eHFqTEJ2YnUzNnpGcW1ETElocjVRc2lXaVJOUDJfdHFhWUwyc25zUHdLUQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T16:34:00+00:00", "published_display": "07 Jul 2026 16:34", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Implied Volatility Surging for Phibro Animal Health Stock Options", "summary": "", "url": "https://finance.yahoo.com/markets/options/articles/implied-volatility-surging-phibro-animal-140900464.html", "source_name": "Zacks", "published_at": "2026-07-06T14:09:00+00:00", "published_display": "06 Jul 2026 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Value Investors Buy Phibro Animal Health (PAHC) Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPTVJPeUdENWhjdFlMZ1RwOGFsT0poSjRFVkUwWnE1VXVwSkRpRXVaUmRQRC0xSndrdmt5Um5sU25hbkx3c1RxUExsbWF2dGFUclhUeFZjRnh4dC1JY284cWlIMnZsb1RLZGRtTnY1MWpsMzFNVExlLVlfMXlWc3lRUnlLVFdVUWVRZ3VaaTFacHJSdHc1QTAyaFVFOU5mck0?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Phibro Animal Health (PAHC) Undervalued After Its Russell Index Removal?", "summary": "Phibro Animal Health (PAHC) has been removed from several Russell indices, impacting potential ownership and liquidity. Despite a recent stock performance dip, the company is considered 29.6% undervalued by analysts, with a fair value target of $45.60 compared to its current $32.", "url": "https://www.sahmcapital.com/news/content/is-phibro-animal-health-pahc-undervalued-after-its-russell-index-removal-2026-07-02", "source_name": "Sahm", "published_at": "2026-07-04T06:11:24", "published_display": "04 Jul 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro (NASDAQ: PAHC) CEO receives 300,000 performance units award", "summary": "Phibro Animal Health Corporation's President and CEO, Daniel M. Bendheim, has been granted 300,000 Performance Stock Units (PSUs). These PSUs represent a contingent right to receive Class A Common Stock, with vesting scheduled for June 30, 2031, subject to the achievement of spec", "url": "https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-e9c63b7a7df9.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:39:48", "published_display": "02 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Rundown: Phibro Animal Health (NASDAQ:PAHC) Vs Other Branded Pharmaceuticals Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNSENfMWdzVUlaLVJEdDktdTdrVEJrU1VkQjhNQzlLaGpJSmFqWkRPeU1WeEFha2o5MlhodGRIZmhsc2lZblRvbk1DbkRCTkIySjVid0x4NE9hQjQzQVp1RVEtcXp0OXNpbWdtQzV6bGQyWjNGZUx4NFRoVmg3ZFJLR3JPOXpRbmkydnJLOFVabnNwbDcxRUpR?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Phibro Animal Health Corporation Class A \u2013 MUN:PB8", "summary": "This article provides financial metrics for Phibro Animal Health Corporation Class A (MUN:PB8) on the Munich Stock Exchange, specifically focusing on its enterprise value to revenue forward. It appears to be a financial data point from TradingView, offering a snapshot of the comp", "url": "https://www.tradingview.com/symbols/MUN-PB8/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T04:39:31", "published_display": "30 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Phibro Animal Health Corporation Class A \u2013 MUN:PB8", "summary": "This article provides financial information for Phibro Animal Health Corporation Class A (MUN:PB8) on the Munich Stock Exchange, specifically focusing on its forward price-to-earnings ratio. It indicates that the market was closed at the time of publication with no trades. The co", "url": "https://www.tradingview.com/symbols/MUN-PB8/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T20:10:54", "published_display": "29 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Phibro Animal Health Corporation Class A \u2013 MUN:PB8", "summary": "This article displays the \"Price to sales forward\" value for Phibro Animal Health Corporation Class A under its Munich Stock Exchange ticker PB8. The financial data provided is limited, indicating that no specific trades or values are currently available. It appears to be a stub ", "url": "https://www.tradingview.com/symbols/MUN-PB8/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T06:13:15", "published_display": "29 Jun 2026 06:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Phibro (NASDAQ: PAHC) CEO granted 300,000 performance-based RSUs", "summary": "Phibro Animal Health Corporation announced the appointment of Daniel (Dani) Bendheim as CEO and President, effective July 1, 2026. His compensation package includes an $850,000 annual base salary, a target 50% annual cash bonus, annual time-vesting RSUs, and an initial grant of 3", "url": "https://www.stocktitan.net/sec-filings/PAHC/8-k-phibro-animal-health-corp-reports-material-event-b176037d7a1c.html", "source_name": "Stock Titan", "published_at": "2026-06-26T19:10:43", "published_display": "26 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Phibro Animal Health Corporation Class A \u2013 GETTEX:PB8", "summary": "The article provides a title for the \"Price to book forward\" metric for Phibro Animal Health Corporation Class A shares traded on GETTEX under the symbol PB8. It indicates that the market is currently closed with no trades. The content seems to be a template or header from a fina", "url": "https://www.tradingview.com/symbols/GETTEX-PB8/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T07:39:27", "published_display": "26 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation Class A Actuals & Estimates (NASDAQ:PAHC)", "summary": "This article provides an overview of Phibro Animal Health Corporation (NASDAQ:PAHC) stock, detailing its current price, market capitalization, and historical performance. It also includes analyst forecasts for future prices, upcoming earnings dates, and financial data such as rev", "url": "https://www.tradingview.com/symbols/NASDAQ-PAHC/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T17:11:08", "published_display": "25 Jun 2026 17:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PHIBRO ANIMAL HEALTH CORP SEC Filing", "summary": "Phibro Animal Health Corporation filed a Form 144 notice, disclosing proposed sales of 281,600 shares of Class A Common Stock. The filing details multiple smaller transactions by BFI Co. LLC, handled by Goldman Sachs & Co. LLC, which occurred between March and May 2026. These fil", "url": "https://www.stocktitan.net/sec-filings/PAHC/144-phibro-animal-health-corp-sec-filing-956e651437c4.html", "source_name": "Stock Titan", "published_at": "2026-06-16T21:41:13", "published_display": "16 Jun 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxONWVNNHRld01aemtueGltdmREbjBmaERyaWhvQXNocmFnY3d2OWFoMVFuVVRvOFdPZzFQTU12M0J0dmhuX0tELXdyTm1vM0ZqSW9ENE83NzY5MGxXNWVoc3Rqbld3b0dVM1JZT1NVT0lSdS1FQVk2VFdIcnMxY0NMRV9QX3F3SmtYSmZhYnctSDM1TGV0eVA5cVpiMXVtYm5Gc0E4Q2RCanZhakdyN2hOY2N2bkZMV0xlN0lZczJ0WGlSMGRMdVZPbnBBcVpFak56a01hZmstYWhOaDRx?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAHC Stock: What's Driving Phibro's Animal Health Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPSktSeldScWF3LWl1RHJucXpRM3plQzN2VmlRR2UwWFJKY3UwYVVWRXZzdGFaS2o4emZzM21oOElmUlNYSG9EU0JNeWJvWEkzS0lLTldEMGZhMXpYbXRjaFhJUEhoZ2ZSWERqTllSMzAtQXN4RmswRGNBYkhmY1BXQ3h2NFJlNmdETVhTS3ItbkppU2NsZHpWbmt5NjM5NkNwdEVz?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Up 10% After Insider Move", "summary": "Phibro Animal Health Corp shares rose over 10% following a director's purchase of Class A shares on the open market after a recent decline, despite ongoing investor concerns about Brazil's regulatory environment and the company's guidance. The company announced a quarterly cash d", "url": "https://www.bez-kabli.pl/phibro-animal-health-up-10-after-insider-move/", "source_name": "Bez Kabli", "published_at": "2026-06-03T15:07:00", "published_display": "03 Jun 2026 15:07", "sentiment": "positive", "sentiment_pct": 64, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Phibro Animal Health (PAHC) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPOGthRlhZYlRFcl83cHNpanVkdlgxdUxGWUFSNUh5SlJFZ2VuNUxCMmIzSFp3WGdWdFU0TktmOWdoQ1FYeXE0Szdnc3ZOQ3pubC1UU3djYzFRTUJzTE1BYWF0ODlHalpGczg1SFZZVGFENXVHNWU2eDBPSDh1ZlVsME45RXdRdzJoM2J1VjZZTHdMTUoyUVhmaU04Q3REdUtKNTZwY1l0ZXZzNmUwR0xKSlkzRjRZQ0hm?oc=5", "source_name": "StockStory", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock", "summary": "Phibro Animal Health Corp. director E. Thomas Corcoran purchased 10,000 shares of the company's Class A Common Stock for $317,700 on May 29, 2026, at a weighted average price of $31.77 per share. This transaction increased his direct holdings to 41,459 shares. The purchase occurr", "url": "https://www.investing.com/news/insider-trading-news/phibro-animal-health-director-e-thomas-corcoran-buys-317700-in-stock-93CH-4723148", "source_name": "Investing.com", "published_at": "2026-06-03T05:09:34", "published_display": "03 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock By Investing.com", "summary": "E. Thomas Corcoran, a director at Phibro Animal Health Corp. (NASDAQ:PAHC), recently purchased 10,000 shares of the company's Class A Common Stock for a total of $317,700. This transaction occurred on May 29, 2026, at an average price of $31.77 per share. Following this purchase,", "url": "https://m.za.investing.com/news/insider-trading-news/phibro-animal-health-director-e-thomas-corcoran-buys-317700-in-stock-93CH-4311335?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-06-03T02:09:56", "published_display": "03 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) director buys 10,000 shares in market", "summary": "E. Thomas Corcoran, a director at Phibro Animal Health (PAHC), purchased 10,000 shares of Class A Common Stock in an open-market transaction. The shares were bought at a weighted average price of $31.77 per share. Following this acquisition, Corcoran directly holds 41,459 shares,", "url": "https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-c8cc0491c306.html", "source_name": "Stock Titan", "published_at": "2026-06-02T23:09:56", "published_display": "02 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Animal Health Market Size & Share | Industry Trends 2035", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE5DYXBqQnFKOTlyMUxXSXRMNGhubDEzbFZtLW40LU1xWjlwRXdYMjc3TktHSEp4T0NaSTJ4dldtQjRyRVQxbE1qQlk4cGplNDhNTGtfeFNxaUhnRTRpUGdQZlZJQTBHWm9TR3lXXzN6RWsxOWZhS18tWmdB?oc=5", "source_name": "Market Research Future", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro's CEO transition puts this insider sale in context", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPV3JEOVdOZFI1T2NCOThEa1h2UHZCOFFqZ2JiQy1FMUlGamhmM09xX1pyWk13NldXdmdDN2dYMENMSDZFTGhnSFlnenVjcXRNQTM1c1lpaTVwYWlTT0IwbUJVOWdRQ0x0UzBvUVIwQy16bTQ3Njg3RFZMLWlfUU53VzdkTkJRdXVjSnJDYzR3Sl9QWGhBWlR4MXc4eGl4Y3lzci1FVHdUMzRweXc?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (NasdaqGM:PAHC) Stock Forecast & Analyst Predictions", "summary": "Phibro Animal Health (PAHC) is forecast to grow earnings by 15.1% and revenue by 3% annually, with EPS expected to increase by 14.9% per annum. Recent updates detail Q3 2026 earnings beats, raised outlooks, and the launch of a new sustainable solutions platform, Verratain. Analys", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/future", "source_name": "Simply Wall Street", "published_at": "2026-05-23T00:09:52", "published_display": "23 May 2026 00:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) major holder adopts 10b5-1 sale plan", "summary": "BFI Co., LLC and Jack C. Bendheim, major holders in Phibro Animal Health (PAHC), have filed an amended Schedule 13D disclosing a new Rule 10b5-1 sales plan. This plan authorizes Goldman Sachs to sell up to 750,000 shares of Class A Common Stock by March 17, 2027, with the first t", "url": "https://www.stocktitan.net/sec-filings/PAHC/schedule-13d-a-phibro-animal-health-corp-amended-major-shareholder-re-1a2235e214fe.html", "source_name": "Stock Titan", "published_at": "2026-05-22T20:42:34", "published_display": "22 May 2026 20:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference", "summary": "Phibro Animal Health Corporation (Nasdaq: PAHC) announced its participation in the Stifel Jaws & Paws Conference. Key executives, including Daniel Bendheim, Larry Miller, and Glenn David, will address financial analysts and investors on May 27, 2026, at 9:45 AM ET in New York. A ", "url": "https://www.businesswire.com/news/home/20260521172103/en/Phibro-Animal-Health-Corporation-to-Participate-in-Stifel-Jaws-Paws-Conference", "source_name": "Business Wire", "published_at": "2026-05-21T20:41:37", "published_display": "21 May 2026 20:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance", "summary": "Phibro Animal Health Corporation announced strong financial results for its third quarter ended March 31, 2026, with net sales increasing by 10% to $383.5 million and adjusted EBITDA rising by 11% to $60.8 million, largely driven by its Animal Health business. The company also up", "url": "https://www.businesswire.com/news/home/20260505351668/en/Phibro-Animal-Health-Corporation-Reports-Third-Quarter-Results-Updates-Financial-Guidance", "source_name": "Business Wire", "published_at": "2026-05-21T11:11:11", "published_display": "21 May 2026 11:11", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q1 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQT3VwY2lxZ3VqQ0VvZHFzbzVtOVpxdFcxYjk1RGVDam8wMlpsNHl6alRfaHJJUnA0NFd3RXZwd2gwNFQwcUtiWklSX2VTcWUzZWVmd0s4ek9GSFRCWS1hNlpmRmRnajVDVHpTeEFmUmlvQWJrTzVYZFRIUU5ncnhENHpicEtCekNKQURhUHJsckFOMUJJMGw2ZGVn?oc=5", "source_name": "Market source", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Barclays PLC holds 263,695 shares in Phibro (NASDAQ: PAHC)", "summary": "Barclays PLC has filed an amended Schedule 13G/A, indicating beneficial ownership of 263,695 shares of Phibro Animal Health Corp-A common stock, which represents 1.27% of the class. The filing specifies that Barclays holds sole voting and dispositive power over these shares. This", "url": "https://www.stocktitan.net/sec-filings/PAHC/schedule-13g-a-phibro-animal-health-corp-amended-passive-investment-d-98ad92e53a8c.html", "source_name": "Stock Titan", "published_at": "2026-05-15T01:40:08", "published_display": "15 May 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNNFhjQkhYNnN2NHBjaU9haVluelhvTWxVY1B2UnpyRmJaR0o1ZlJHNjYwU2hKZkE2NTFFTW9mQTd1a2R2S0xsdXN0Q3phUmN1OHhNMzRXWTFzbFJsNHhtR0ctNXlBc0N2VUp1dzR3Q1liTGxPSnBCbGJzbEx0M19objVwX0ZFendxWXlNWkpWX1pPY1UzYzNHUEhaSUtQQjlJdXc?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPZks0TEtUTHFIdVdSbkZDZmR2SS16YVJpOUxjeWhxOG5LZ041WWNYdDlmWUN1dHRxSzc2QUxubWxBTklrZ0I0Ymx5TWpBWjF5MnZLX09aV0Z6eFd5R083SC1rM1pUWkpoTjNkQ1BTSmpaR3hBeWxzTlFIbnVYbVdkaHpFZlc4Mks1eWFVeElfcVlhNFpzaEZsMm1R?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPajVGSkJLb1FINFUxUERfTFVPa1ZzeVh2RS1tTXZEYU1uRldDakhqcVVzejV1WEVlSTFETWFoWGVfb1NNa3JmOV9MbGlrMmRyaUtmZ0UtZEhGTWdZNjVVcVNpQUZRTVlwdGZJVEtPOEtNbmoxQ1N3RFpNTHA5a1lJSThkWjlZSTdfUEhWLU0ybU9sdzFObnZ6WEdB?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Down 30.9% in 4 Weeks, Here's Why Phibro (PAHC) Looks Ripe for a Turnaround", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQUERTM0pwSzRBOGQwVGNKdnZadGs1NkFiZUE5aE1RVVNHUXh5Sm9PYjJnalZiNlBtdlFNZ3RjWWp0UFFvM3l1SlhFaHl4MVVNck5jWnV3UVo1VVBmbHFmZ0UwOHpVYnZmdDlBRmYtbDhDZGIzR2Q5eEx3TGdnU2RMOXY4bTdKMjlQUHc?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Margin Reset To 6.3% Tests Bullish Expansion Narrative", "summary": "Phibro Animal Health (PAHC) recently reported Q3 2026 results with revenue of US$383.5 million and EPS of US$0.59. The company's trailing 12-month net profit margin is 6.3%, up from 2.7% previously, but quarterly net income has been stable between US$24.0 million and US$27.5 mill", "url": "https://www.sahmcapital.com/news/content/phibro-animal-health-pahc-margin-reset-to-63-tests-bullish-expansion-narrative-2026-05-08", "source_name": "Sahm", "published_at": "2026-05-09T06:09:09", "published_display": "09 May 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation Declares Quarterly Dividend", "summary": "Phibro Animal Health Corporation (Nasdaq: PAHC) announced a quarterly cash dividend of $0.12 per share for its Class A and Class B common stock. The dividend is payable on June 24, 2026, to shareholders of record as of June 3, 2026. Phibro Animal Health Corporation is a global an", "url": "https://finance.yahoo.com/markets/stocks/articles/phibro-animal-health-corporation-declares-203000895.html", "source_name": "Market source", "published_at": "2026-05-08T07:40:08", "published_display": "08 May 2026 07:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference", "summary": "Phibro Animal Health Corporation announced its participation in the Bank of America Securities Health Care Conference. Key executives, including Daniel Bendheim, Larry Miller, and Glenn David, will address financial analysts and investors on May 13, 2026, at 1:40 PM ET. A live au", "url": "https://www.businesswire.com/news/home/20260507416930/en/Phibro-Animal-Health-Corporation-to-Participate-in-Bank-of-America-Securities-Health-Care-Conference", "source_name": "Business Wire", "published_at": "2026-05-08T04:39:48", "published_display": "08 May 2026 04:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health CEO Jack Bendheim sells $1.02m in PAHC shares", "summary": "Phibro Animal Health CEO Jack Bendheim, along with BFI Co., LLC, sold Class A Common Stock worth approximately $1.02 million between May 5 and May 7, 2026, under a Rule 10b5-1 trading plan. These sales involved 18,608 shares at prices ranging from $47.5908 to $58.1257, occurring ", "url": "https://m.investing.com/news/insider-trading-news/phibro-animal-health-ceo-jack-bendheim-sells-102m-in-pahc-shares-93CH-4670565?ampMode=1", "source_name": "Investing.com", "published_at": "2026-05-08T00:39:48", "published_display": "08 May 2026 00:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CEO-linked BFI Co. (PAHC) sells 18,608 Phibro shares under plan", "summary": "BFI Co., LLC, an entity linked to Phibro Animal Health's CEO Jack Bendheim, sold 18,608 shares of Class A Common Stock between May 5-7, 2026, under a pre-arranged Rule 10b5-1 trading plan. The shares were sold in open-market transactions at weighted average prices ranging from ap", "url": "https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-45fe3e3f3d20.html", "source_name": "Stock Titan", "published_at": "2026-05-07T23:39:48", "published_display": "07 May 2026 23:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Is Up 11.4% After Strong Q3 Earnings And New Sustainability Push \u2013 What's Changed", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro executives take Bank of America health conference stage May 13", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQci12aVhHU2hTSGNZMFROeGxZbURmY2s2dlBxWFBmbERwd0ZDZjFqTVl2QmlzVEN3bnRsR0ctMUtQamoyemZJbTVQd3d0Y0Q3bWxsYnVKU3QwYnVGN1RqQ3BKbnpIczd3em1CdmZqNU5jTmdvWmVZZGxuWWstNXVEOWxDUEh0c1Q5SXVGb0wtSS1sNDFheURBNncwcXBQNjhYODhTMVhmdWc5UVgzVzY0a2Y3ZkI2U1JhWkJWOEF3?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN\u2122 Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership", "summary": "Phibro Animal Health Corporation has launched its Sustainable Solutions Platform (SSP), a companywide initiative to help animal protein, dairy, and petfood producers reduce greenhouse gas emissions. As part of this, Phibro introduced Verratain\u2122 Verified Sustainability Solutions, ", "url": "https://www.businesswire.com/news/home/20260505692758/en/Phibro-Animal-Health-Corporation-Launches-Companywide-Sustainable-Solutions-Platform-Introduces-VERRATAIN-Verified-Sustainability-Solutions-Through-Strategic-VAXA-Technologies-Partnership", "source_name": "Business Wire", "published_at": "2026-05-06T06:09:10", "published_display": "06 May 2026 06:09", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health declares $0.12 quarterly dividend payable June 24", "summary": "Phibro Animal Health (PAHC) has declared a quarterly cash dividend of $0.12 per share for both Class A and Class B common stock. This dividend is payable on June 24, 2026, to shareholders of record as of June 3, 2026. The declaration was announced on May 5, 2026, and details were", "url": "https://www.tradingview.com/news/tradingview:5e975a31f210e:0-phibro-animal-health-declares-0-12-quarterly-dividend-payable-june-24/", "source_name": "TradingView", "published_at": "2026-05-06T05:09:33", "published_display": "06 May 2026 05:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] PHIBRO ANIMAL HEALTH CORP Reports Material Event", "summary": "Phibro Animal Health Corporation announced an 8-K material event, declaring a quarterly cash dividend of $0.12 per share for both Class A and Class B common stock. The dividend will be paid on June 24, 2026, to stockholders recorded by June 3, 2026. This filing, deemed a moderate", "url": "https://www.stocktitan.net/sec-filings/PAHC/8-k-phibro-animal-health-corp-reports-material-event-94aca222c82a.html", "source_name": "Stock Titan", "published_at": "2026-05-05T20:40:06", "published_display": "05 May 2026 20:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPMy16bExiWjRLRUpucWlfblFoTW1HZlpDcll6VF94cEZQd1ZVNExfTzY3RVdBNGRSVlZkOVNWa2xhb1lQZlJEUFA1Nmd5UVlVQzJ2akNnZG9QQTlnMEZvd1dqMnFCRmZJQ1RhSnNGY0t1MEdGYWREb0F4UWtCQlprRE1sV2lMQnFsQm8tMHBMNEpsc3NZVExOVGJYa3VnM0w0cHhpRg?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-07T08:00:00+00:00", "published_display": "07 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Is Up 25.3% After Issuing 2026 Sales And EPS Guidance - What's Changed", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE54WEJNRGdfb1ZGeS1xVlR0ZnBtTjZMVE83bWVaMXlKbXlhV0Z6T2VqanFQc0hsUFpHcUVmWDl0QkNvMG50SVpqczlIc2o0Qk1FNEdXeDlEdUVzU2JvNE9nQlQxQXl4MGNEZ2ZTLVNSMG5PY3ZSOUhTXzk0QnVBNTQ?oc=5", "source_name": "Market source", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Phibro Animal Health (PAHC) After Russell Index Removals And The Case For Undervaluation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-10T05:15:25+00:00", "published_display": "10 Jul 2026 05:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Leaves Russell Indexes, Is The Stock A Bargain?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOQ1RjUWphNFpicVRVUFZVdXV4YmtxaldtTkVYYW0zMm5wcTlENEJ5bU9vY1NnV0hTZW9TOWg1b0NDVFRsVU1rdWcyOURvN2dkQzRraWZiRFNJdmRTTHJIWGdIckpzSXVlZ19xV2lKR29XRmFnNXlSTnB0TjFpMURoVXY2Y0NZbm1CT1FlV0theE0xcVE0MW1LTmFSUko2Zw?oc=5", "source_name": "Market source", "published_at": "2026-07-09T15:10:11+00:00", "published_display": "09 Jul 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Stock Looks Reasonable On Value But Stretched After 138% Gain", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQcjlFUzl2WDlIRkdTZXZWTVZsMmM3ZU9EN1VrNUhRajNXU0h5NzZMWTFubVQyUWhBb1JkWlUxSE1sdFFyRnYtNllsYUhLaGt4MkFzWFRYalJZNkpZNzhyOGg2akh3X3pjOWY4T1lRVFExNThXcFdNd2lXbm1BaWY1anR3WTNHamV4bnF6RDlQTzJMY083cVltTDRRSzc?oc=5", "source_name": "Market source", "published_at": "2026-07-09T10:12:39+00:00", "published_display": "09 Jul 2026 10:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Stock Loses Russell Index Spots And Investor Visibility", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPUm5qOHAzdFVVTjZDLWE1cXJWb1c1NlJjMURGSXlQS2RpRUUwS0plZUVZTE9yZUdUZ2JiWHgteG9QbnhtaV83R19tZXhMYXlRNE9nb3N2SjNaZHhSeEw2LXZqU2pkY3l2RUFPOWlqVzhkMVMtdVFrM1ZIMkQyX0J6QUFFUndJRUt0SW53ZUVTNVZIV3lJUUhkSDlCM1c?oc=5", "source_name": "Market source", "published_at": "2026-07-09T06:14:00+00:00", "published_display": "09 Jul 2026 06:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Las ETF que invierten en acciones de Phibro Animal Health Corporation Class A", "summary": "This article lists various ETFs that invest in Phibro Animal Health Corporation Class A stock, primarily focusing on small-cap and healthcare-related funds. It provides detailed financial data for each ETF, including market value, weight, issuer, management style, expense ratio, ", "url": "https://es.tradingview.com/symbols/FWB-PB8/etfs/", "source_name": "TradingView", "published_at": "2026-07-09T06:41:17", "published_display": "09 Jul 2026 06:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Stock Still Looks Below Fair Value Despite A 143% Return", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T22:53:07+00:00", "published_display": "08 Jul 2026 22:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chewy's Market Share Gains Are Driven by Health and Customer Loyalty", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQZEg0YW1rbEZTdkdhUDV4alFFRjBBQXZSVi00Z1RaY0FHa0xUTEtjY0ZKM01sak94dncyd2lTMmxHRjJfbXVLUEQzTE90bGVwZHcydkxZM3NjeGY0UUpnbnRmSlRscDRPT0pWbjFfX0QxbFJVZWxQZjF3by1BSDdzTWx2ZVRjc0FoZG1uSktBU3U4Z2dRVXY3eHFqTEJ2YnUzNnpGcW1ETElocjVRc2lXaVJOUDJfdHFhWUwyc25zUHdLUQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T16:34:00+00:00", "published_display": "07 Jul 2026 16:34", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Implied Volatility Surging for Phibro Animal Health Stock Options", "summary": "", "url": "https://finance.yahoo.com/markets/options/articles/implied-volatility-surging-phibro-animal-140900464.html", "source_name": "Zacks", "published_at": "2026-07-06T14:09:00+00:00", "published_display": "06 Jul 2026 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Value Investors Buy Phibro Animal Health (PAHC) Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPTVJPeUdENWhjdFlMZ1RwOGFsT0poSjRFVkUwWnE1VXVwSkRpRXVaUmRQRC0xSndrdmt5Um5sU25hbkx3c1RxUExsbWF2dGFUclhUeFZjRnh4dC1JY284cWlIMnZsb1RLZGRtTnY1MWpsMzFNVExlLVlfMXlWc3lRUnlLVFdVUWVRZ3VaaTFacHJSdHc1QTAyaFVFOU5mck0?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Phibro Animal Health (PAHC) Undervalued After Its Russell Index Removal?", "summary": "Phibro Animal Health (PAHC) has been removed from several Russell indices, impacting potential ownership and liquidity. Despite a recent stock performance dip, the company is considered 29.6% undervalued by analysts, with a fair value target of $45.60 compared to its current $32.", "url": "https://www.sahmcapital.com/news/content/is-phibro-animal-health-pahc-undervalued-after-its-russell-index-removal-2026-07-02", "source_name": "Sahm", "published_at": "2026-07-04T06:11:24", "published_display": "04 Jul 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro (NASDAQ: PAHC) CEO receives 300,000 performance units award", "summary": "Phibro Animal Health Corporation's President and CEO, Daniel M. Bendheim, has been granted 300,000 Performance Stock Units (PSUs). These PSUs represent a contingent right to receive Class A Common Stock, with vesting scheduled for June 30, 2031, subject to the achievement of spec", "url": "https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-e9c63b7a7df9.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:39:48", "published_display": "02 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Rundown: Phibro Animal Health (NASDAQ:PAHC) Vs Other Branded Pharmaceuticals Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNSENfMWdzVUlaLVJEdDktdTdrVEJrU1VkQjhNQzlLaGpJSmFqWkRPeU1WeEFha2o5MlhodGRIZmhsc2lZblRvbk1DbkRCTkIySjVid0x4NE9hQjQzQVp1RVEtcXp0OXNpbWdtQzV6bGQyWjNGZUx4NFRoVmg3ZFJLR3JPOXpRbmkydnJLOFVabnNwbDcxRUpR?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Phibro Animal Health Corporation Class A \u2013 MUN:PB8", "summary": "This article provides financial metrics for Phibro Animal Health Corporation Class A (MUN:PB8) on the Munich Stock Exchange, specifically focusing on its enterprise value to revenue forward. It appears to be a financial data point from TradingView, offering a snapshot of the comp", "url": "https://www.tradingview.com/symbols/MUN-PB8/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T04:39:31", "published_display": "30 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Phibro Animal Health Corporation Class A \u2013 MUN:PB8", "summary": "This article provides financial information for Phibro Animal Health Corporation Class A (MUN:PB8) on the Munich Stock Exchange, specifically focusing on its forward price-to-earnings ratio. It indicates that the market was closed at the time of publication with no trades. The co", "url": "https://www.tradingview.com/symbols/MUN-PB8/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T20:10:54", "published_display": "29 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Phibro Animal Health Corporation Class A \u2013 MUN:PB8", "summary": "This article displays the \"Price to sales forward\" value for Phibro Animal Health Corporation Class A under its Munich Stock Exchange ticker PB8. The financial data provided is limited, indicating that no specific trades or values are currently available. It appears to be a stub ", "url": "https://www.tradingview.com/symbols/MUN-PB8/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T06:13:15", "published_display": "29 Jun 2026 06:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Phibro (NASDAQ: PAHC) CEO granted 300,000 performance-based RSUs", "summary": "Phibro Animal Health Corporation announced the appointment of Daniel (Dani) Bendheim as CEO and President, effective July 1, 2026. His compensation package includes an $850,000 annual base salary, a target 50% annual cash bonus, annual time-vesting RSUs, and an initial grant of 3", "url": "https://www.stocktitan.net/sec-filings/PAHC/8-k-phibro-animal-health-corp-reports-material-event-b176037d7a1c.html", "source_name": "Stock Titan", "published_at": "2026-06-26T19:10:43", "published_display": "26 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Phibro Animal Health Corporation Class A \u2013 GETTEX:PB8", "summary": "The article provides a title for the \"Price to book forward\" metric for Phibro Animal Health Corporation Class A shares traded on GETTEX under the symbol PB8. It indicates that the market is currently closed with no trades. The content seems to be a template or header from a fina", "url": "https://www.tradingview.com/symbols/GETTEX-PB8/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T07:39:27", "published_display": "26 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation Class A Actuals & Estimates (NASDAQ:PAHC)", "summary": "This article provides an overview of Phibro Animal Health Corporation (NASDAQ:PAHC) stock, detailing its current price, market capitalization, and historical performance. It also includes analyst forecasts for future prices, upcoming earnings dates, and financial data such as rev", "url": "https://www.tradingview.com/symbols/NASDAQ-PAHC/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T17:11:08", "published_display": "25 Jun 2026 17:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PHIBRO ANIMAL HEALTH CORP SEC Filing", "summary": "Phibro Animal Health Corporation filed a Form 144 notice, disclosing proposed sales of 281,600 shares of Class A Common Stock. The filing details multiple smaller transactions by BFI Co. LLC, handled by Goldman Sachs & Co. LLC, which occurred between March and May 2026. These fil", "url": "https://www.stocktitan.net/sec-filings/PAHC/144-phibro-animal-health-corp-sec-filing-956e651437c4.html", "source_name": "Stock Titan", "published_at": "2026-06-16T21:41:13", "published_display": "16 Jun 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxONWVNNHRld01aemtueGltdmREbjBmaERyaWhvQXNocmFnY3d2OWFoMVFuVVRvOFdPZzFQTU12M0J0dmhuX0tELXdyTm1vM0ZqSW9ENE83NzY5MGxXNWVoc3Rqbld3b0dVM1JZT1NVT0lSdS1FQVk2VFdIcnMxY0NMRV9QX3F3SmtYSmZhYnctSDM1TGV0eVA5cVpiMXVtYm5Gc0E4Q2RCanZhakdyN2hOY2N2bkZMV0xlN0lZczJ0WGlSMGRMdVZPbnBBcVpFak56a01hZmstYWhOaDRx?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAHC Stock: What's Driving Phibro's Animal Health Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPSktSeldScWF3LWl1RHJucXpRM3plQzN2VmlRR2UwWFJKY3UwYVVWRXZzdGFaS2o4emZzM21oOElmUlNYSG9EU0JNeWJvWEkzS0lLTldEMGZhMXpYbXRjaFhJUEhoZ2ZSWERqTllSMzAtQXN4RmswRGNBYkhmY1BXQ3h2NFJlNmdETVhTS3ItbkppU2NsZHpWbmt5NjM5NkNwdEVz?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Up 10% After Insider Move", "summary": "Phibro Animal Health Corp shares rose over 10% following a director's purchase of Class A shares on the open market after a recent decline, despite ongoing investor concerns about Brazil's regulatory environment and the company's guidance. The company announced a quarterly cash d", "url": "https://www.bez-kabli.pl/phibro-animal-health-up-10-after-insider-move/", "source_name": "Bez Kabli", "published_at": "2026-06-03T15:07:00", "published_display": "03 Jun 2026 15:07", "sentiment": "positive", "sentiment_pct": 64, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Phibro Animal Health (PAHC) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPOGthRlhZYlRFcl83cHNpanVkdlgxdUxGWUFSNUh5SlJFZ2VuNUxCMmIzSFp3WGdWdFU0TktmOWdoQ1FYeXE0Szdnc3ZOQ3pubC1UU3djYzFRTUJzTE1BYWF0ODlHalpGczg1SFZZVGFENXVHNWU2eDBPSDh1ZlVsME45RXdRdzJoM2J1VjZZTHdMTUoyUVhmaU04Q3REdUtKNTZwY1l0ZXZzNmUwR0xKSlkzRjRZQ0hm?oc=5", "source_name": "StockStory", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock", "summary": "Phibro Animal Health Corp. director E. Thomas Corcoran purchased 10,000 shares of the company's Class A Common Stock for $317,700 on May 29, 2026, at a weighted average price of $31.77 per share. This transaction increased his direct holdings to 41,459 shares. The purchase occurr", "url": "https://www.investing.com/news/insider-trading-news/phibro-animal-health-director-e-thomas-corcoran-buys-317700-in-stock-93CH-4723148", "source_name": "Investing.com", "published_at": "2026-06-03T05:09:34", "published_display": "03 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock By Investing.com", "summary": "E. Thomas Corcoran, a director at Phibro Animal Health Corp. (NASDAQ:PAHC), recently purchased 10,000 shares of the company's Class A Common Stock for a total of $317,700. This transaction occurred on May 29, 2026, at an average price of $31.77 per share. Following this purchase,", "url": "https://m.za.investing.com/news/insider-trading-news/phibro-animal-health-director-e-thomas-corcoran-buys-317700-in-stock-93CH-4311335?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-06-03T02:09:56", "published_display": "03 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) director buys 10,000 shares in market", "summary": "E. Thomas Corcoran, a director at Phibro Animal Health (PAHC), purchased 10,000 shares of Class A Common Stock in an open-market transaction. The shares were bought at a weighted average price of $31.77 per share. Following this acquisition, Corcoran directly holds 41,459 shares,", "url": "https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-c8cc0491c306.html", "source_name": "Stock Titan", "published_at": "2026-06-02T23:09:56", "published_display": "02 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Animal Health Market Size & Share | Industry Trends 2035", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE5DYXBqQnFKOTlyMUxXSXRMNGhubDEzbFZtLW40LU1xWjlwRXdYMjc3TktHSEp4T0NaSTJ4dldtQjRyRVQxbE1qQlk4cGplNDhNTGtfeFNxaUhnRTRpUGdQZlZJQTBHWm9TR3lXXzN6RWsxOWZhS18tWmdB?oc=5", "source_name": "Market Research Future", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro's CEO transition puts this insider sale in context", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPV3JEOVdOZFI1T2NCOThEa1h2UHZCOFFqZ2JiQy1FMUlGamhmM09xX1pyWk13NldXdmdDN2dYMENMSDZFTGhnSFlnenVjcXRNQTM1c1lpaTVwYWlTT0IwbUJVOWdRQ0x0UzBvUVIwQy16bTQ3Njg3RFZMLWlfUU53VzdkTkJRdXVjSnJDYzR3Sl9QWGhBWlR4MXc4eGl4Y3lzci1FVHdUMzRweXc?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (NasdaqGM:PAHC) Stock Forecast & Analyst Predictions", "summary": "Phibro Animal Health (PAHC) is forecast to grow earnings by 15.1% and revenue by 3% annually, with EPS expected to increase by 14.9% per annum. Recent updates detail Q3 2026 earnings beats, raised outlooks, and the launch of a new sustainable solutions platform, Verratain. Analys", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pahc/phibro-animal-health/future", "source_name": "Simply Wall Street", "published_at": "2026-05-23T00:09:52", "published_display": "23 May 2026 00:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) major holder adopts 10b5-1 sale plan", "summary": "BFI Co., LLC and Jack C. Bendheim, major holders in Phibro Animal Health (PAHC), have filed an amended Schedule 13D disclosing a new Rule 10b5-1 sales plan. This plan authorizes Goldman Sachs to sell up to 750,000 shares of Class A Common Stock by March 17, 2027, with the first t", "url": "https://www.stocktitan.net/sec-filings/PAHC/schedule-13d-a-phibro-animal-health-corp-amended-major-shareholder-re-1a2235e214fe.html", "source_name": "Stock Titan", "published_at": "2026-05-22T20:42:34", "published_display": "22 May 2026 20:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference", "summary": "Phibro Animal Health Corporation (Nasdaq: PAHC) announced its participation in the Stifel Jaws & Paws Conference. Key executives, including Daniel Bendheim, Larry Miller, and Glenn David, will address financial analysts and investors on May 27, 2026, at 9:45 AM ET in New York. A ", "url": "https://www.businesswire.com/news/home/20260521172103/en/Phibro-Animal-Health-Corporation-to-Participate-in-Stifel-Jaws-Paws-Conference", "source_name": "Business Wire", "published_at": "2026-05-21T20:41:37", "published_display": "21 May 2026 20:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance", "summary": "Phibro Animal Health Corporation announced strong financial results for its third quarter ended March 31, 2026, with net sales increasing by 10% to $383.5 million and adjusted EBITDA rising by 11% to $60.8 million, largely driven by its Animal Health business. The company also up", "url": "https://www.businesswire.com/news/home/20260505351668/en/Phibro-Animal-Health-Corporation-Reports-Third-Quarter-Results-Updates-Financial-Guidance", "source_name": "Business Wire", "published_at": "2026-05-21T11:11:11", "published_display": "21 May 2026 11:11", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q1 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQT3VwY2lxZ3VqQ0VvZHFzbzVtOVpxdFcxYjk1RGVDam8wMlpsNHl6alRfaHJJUnA0NFd3RXZwd2gwNFQwcUtiWklSX2VTcWUzZWVmd0s4ek9GSFRCWS1hNlpmRmRnajVDVHpTeEFmUmlvQWJrTzVYZFRIUU5ncnhENHpicEtCekNKQURhUHJsckFOMUJJMGw2ZGVn?oc=5", "source_name": "Market source", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Barclays PLC holds 263,695 shares in Phibro (NASDAQ: PAHC)", "summary": "Barclays PLC has filed an amended Schedule 13G/A, indicating beneficial ownership of 263,695 shares of Phibro Animal Health Corp-A common stock, which represents 1.27% of the class. The filing specifies that Barclays holds sole voting and dispositive power over these shares. This", "url": "https://www.stocktitan.net/sec-filings/PAHC/schedule-13g-a-phibro-animal-health-corp-amended-passive-investment-d-98ad92e53a8c.html", "source_name": "Stock Titan", "published_at": "2026-05-15T01:40:08", "published_display": "15 May 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNNFhjQkhYNnN2NHBjaU9haVluelhvTWxVY1B2UnpyRmJaR0o1ZlJHNjYwU2hKZkE2NTFFTW9mQTd1a2R2S0xsdXN0Q3phUmN1OHhNMzRXWTFzbFJsNHhtR0ctNXlBc0N2VUp1dzR3Q1liTGxPSnBCbGJzbEx0M19objVwX0ZFendxWXlNWkpWX1pPY1UzYzNHUEhaSUtQQjlJdXc?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPZks0TEtUTHFIdVdSbkZDZmR2SS16YVJpOUxjeWhxOG5LZ041WWNYdDlmWUN1dHRxSzc2QUxubWxBTklrZ0I0Ymx5TWpBWjF5MnZLX09aV0Z6eFd5R083SC1rM1pUWkpoTjNkQ1BTSmpaR3hBeWxzTlFIbnVYbVdkaHpFZlc4Mks1eWFVeElfcVlhNFpzaEZsMm1R?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPajVGSkJLb1FINFUxUERfTFVPa1ZzeVh2RS1tTXZEYU1uRldDakhqcVVzejV1WEVlSTFETWFoWGVfb1NNa3JmOV9MbGlrMmRyaUtmZ0UtZEhGTWdZNjVVcVNpQUZRTVlwdGZJVEtPOEtNbmoxQ1N3RFpNTHA5a1lJSThkWjlZSTdfUEhWLU0ybU9sdzFObnZ6WEdB?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Down 30.9% in 4 Weeks, Here's Why Phibro (PAHC) Looks Ripe for a Turnaround", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQUERTM0pwSzRBOGQwVGNKdnZadGs1NkFiZUE5aE1RVVNHUXh5Sm9PYjJnalZiNlBtdlFNZ3RjWWp0UFFvM3l1SlhFaHl4MVVNck5jWnV3UVo1VVBmbHFmZ0UwOHpVYnZmdDlBRmYtbDhDZGIzR2Q5eEx3TGdnU2RMOXY4bTdKMjlQUHc?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Margin Reset To 6.3% Tests Bullish Expansion Narrative", "summary": "Phibro Animal Health (PAHC) recently reported Q3 2026 results with revenue of US$383.5 million and EPS of US$0.59. The company's trailing 12-month net profit margin is 6.3%, up from 2.7% previously, but quarterly net income has been stable between US$24.0 million and US$27.5 mill", "url": "https://www.sahmcapital.com/news/content/phibro-animal-health-pahc-margin-reset-to-63-tests-bullish-expansion-narrative-2026-05-08", "source_name": "Sahm", "published_at": "2026-05-09T06:09:09", "published_display": "09 May 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation Declares Quarterly Dividend", "summary": "Phibro Animal Health Corporation (Nasdaq: PAHC) announced a quarterly cash dividend of $0.12 per share for its Class A and Class B common stock. The dividend is payable on June 24, 2026, to shareholders of record as of June 3, 2026. Phibro Animal Health Corporation is a global an", "url": "https://finance.yahoo.com/markets/stocks/articles/phibro-animal-health-corporation-declares-203000895.html", "source_name": "Market source", "published_at": "2026-05-08T07:40:08", "published_display": "08 May 2026 07:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference", "summary": "Phibro Animal Health Corporation announced its participation in the Bank of America Securities Health Care Conference. Key executives, including Daniel Bendheim, Larry Miller, and Glenn David, will address financial analysts and investors on May 13, 2026, at 1:40 PM ET. A live au", "url": "https://www.businesswire.com/news/home/20260507416930/en/Phibro-Animal-Health-Corporation-to-Participate-in-Bank-of-America-Securities-Health-Care-Conference", "source_name": "Business Wire", "published_at": "2026-05-08T04:39:48", "published_display": "08 May 2026 04:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health CEO Jack Bendheim sells $1.02m in PAHC shares", "summary": "Phibro Animal Health CEO Jack Bendheim, along with BFI Co., LLC, sold Class A Common Stock worth approximately $1.02 million between May 5 and May 7, 2026, under a Rule 10b5-1 trading plan. These sales involved 18,608 shares at prices ranging from $47.5908 to $58.1257, occurring ", "url": "https://m.investing.com/news/insider-trading-news/phibro-animal-health-ceo-jack-bendheim-sells-102m-in-pahc-shares-93CH-4670565?ampMode=1", "source_name": "Investing.com", "published_at": "2026-05-08T00:39:48", "published_display": "08 May 2026 00:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CEO-linked BFI Co. (PAHC) sells 18,608 Phibro shares under plan", "summary": "BFI Co., LLC, an entity linked to Phibro Animal Health's CEO Jack Bendheim, sold 18,608 shares of Class A Common Stock between May 5-7, 2026, under a pre-arranged Rule 10b5-1 trading plan. The shares were sold in open-market transactions at weighted average prices ranging from ap", "url": "https://www.stocktitan.net/sec-filings/PAHC/form-4-phibro-animal-health-corp-insider-trading-activity-45fe3e3f3d20.html", "source_name": "Stock Titan", "published_at": "2026-05-07T23:39:48", "published_display": "07 May 2026 23:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Is Up 11.4% After Strong Q3 Earnings And New Sustainability Push \u2013 What's Changed", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro executives take Bank of America health conference stage May 13", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQci12aVhHU2hTSGNZMFROeGxZbURmY2s2dlBxWFBmbERwd0ZDZjFqTVl2QmlzVEN3bnRsR0ctMUtQamoyemZJbTVQd3d0Y0Q3bWxsYnVKU3QwYnVGN1RqQ3BKbnpIczd3em1CdmZqNU5jTmdvWmVZZGxuWWstNXVEOWxDUEh0c1Q5SXVGb0wtSS1sNDFheURBNncwcXBQNjhYODhTMVhmdWc5UVgzVzY0a2Y3ZkI2U1JhWkJWOEF3?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN\u2122 Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership", "summary": "Phibro Animal Health Corporation has launched its Sustainable Solutions Platform (SSP), a companywide initiative to help animal protein, dairy, and petfood producers reduce greenhouse gas emissions. As part of this, Phibro introduced Verratain\u2122 Verified Sustainability Solutions, ", "url": "https://www.businesswire.com/news/home/20260505692758/en/Phibro-Animal-Health-Corporation-Launches-Companywide-Sustainable-Solutions-Platform-Introduces-VERRATAIN-Verified-Sustainability-Solutions-Through-Strategic-VAXA-Technologies-Partnership", "source_name": "Business Wire", "published_at": "2026-05-06T06:09:10", "published_display": "06 May 2026 06:09", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health declares $0.12 quarterly dividend payable June 24", "summary": "Phibro Animal Health (PAHC) has declared a quarterly cash dividend of $0.12 per share for both Class A and Class B common stock. This dividend is payable on June 24, 2026, to shareholders of record as of June 3, 2026. The declaration was announced on May 5, 2026, and details were", "url": "https://www.tradingview.com/news/tradingview:5e975a31f210e:0-phibro-animal-health-declares-0-12-quarterly-dividend-payable-june-24/", "source_name": "TradingView", "published_at": "2026-05-06T05:09:33", "published_display": "06 May 2026 05:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] PHIBRO ANIMAL HEALTH CORP Reports Material Event", "summary": "Phibro Animal Health Corporation announced an 8-K material event, declaring a quarterly cash dividend of $0.12 per share for both Class A and Class B common stock. The dividend will be paid on June 24, 2026, to stockholders recorded by June 3, 2026. This filing, deemed a moderate", "url": "https://www.stocktitan.net/sec-filings/PAHC/8-k-phibro-animal-health-corp-reports-material-event-94aca222c82a.html", "source_name": "Stock Titan", "published_at": "2026-05-05T20:40:06", "published_display": "05 May 2026 20:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPMy16bExiWjRLRUpucWlfblFoTW1HZlpDcll6VF94cEZQd1ZVNExfTzY3RVdBNGRSVlZkOVNWa2xhb1lQZlJEUFA1Nmd5UVlVQzJ2akNnZG9QQTlnMEZvd1dqMnFCRmZJQ1RhSnNGY0t1MEdGYWREb0F4UWtCQlprRE1sV2lMQnFsQm8tMHBMNEpsc3NZVExOVGJYa3VnM0w0cHhpRg?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-07T08:00:00+00:00", "published_display": "07 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phibro Animal Health (PAHC) Is Up 25.3% After Issuing 2026 Sales And EPS Guidance - What's Changed", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE54WEJNRGdfb1ZGeS1xVlR0ZnBtTjZMVE83bWVaMXlKbXlhV0Z6T2VqanFQc0hsUFpHcUVmWDl0QkNvMG50SVpqczlIc2o0Qk1FNEdXeDlEdUVzU2JvNE9nQlQxQXl4MGNEZ2ZTLVNSMG5PY3ZSOUhTXzk0QnVBNTQ?oc=5", "source_name": "Market source", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 90, "total_relevant": 52, "sentiment_summary": {"positive": 21, "negative": 2, "neutral": 29, "score": 56, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 18.5, "count": 33}, {"event": "earnings", "label": "Earnings", "weight": 6.05, "count": 11}, {"event": "capital_return", "label": "Capital return", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 21, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 32.07, "latest_week": "2026-07-10", "one_week_move": -3.6, "four_week_move": 1.7, "twelve_week_move": -43.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.096572, "market_dynamics_buy_signal": false, "relative_strength": -32.483083, "fair_value_gap": 28.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 48.5471, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.6% over one week, +1.7% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 66, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 14}, {"label": "Stock Titan", "count": 9}, {"label": "TradingView", "count": 8}, {"label": "simplywall.st", "count": 4}, {"label": "Business Wire", "count": 4}, {"label": "The Motley Fool", "count": 3}, {"label": "Sahm", "count": 2}, {"label": "Investing.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 33}, {"label": "Earnings", "count": 11}, {"label": "Capital return", "count": 3}, {"label": "Analyst action", "count": 2}, {"label": "Deals and strategy", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.6% over one week, +1.7% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Phibro Animal Health (PAHC) After Russell Index Removals And The Case For Undervaluation"}], "updated_at": "2026-07-16T07:04:10.272635+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}